Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.
Other companies in Heron Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Heron Therapeutics has a consensus price target of $6.50.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $0.30395 last updated August 26, 2026 at 11:14 AM EDT.
There are no upcoming dividends for Heron Therapeutics.
Heron Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.